# Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

> **NCT01288391** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 15 (actual)

## Conditions studied

- Congenital Bleeding Disorder
- Haemophilia A
- Haemophilia B

## Interventions

- **DRUG:** NNC 0128-0000-2011
- **DRUG:** NNC 0128-0000-2011

## Key facts

- **NCT ID:** NCT01288391
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288391, "Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01288391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*